Skip to Content

Join the 'Alpha 1-Proteinase Inhibitor' group to help and get support from people like you.

Alpha 1-Proteinase Inhibitor News

Kamada Wins FDA Approval for Glassia - a New Liquid, Ready-to-Use Treatment for Alpha-1 Antitrypsin Deficiency

Posted 7 Jul 2010 by Drugs.com

NESS ZIONA, Israel--(BUSINESS WIRE)--Jul 6, 2010 - Kamada today announced that the United States Food and Drug Administration (FDA) has approved Glassia (Alpha 1 Proteinase inhibitor, also known as Alpha-1-Antitrypsin (AAT) for the treatment of Alpha 1 deficiency (AATD). Glassia is now the first and only liquid Alpha- 1-Proteinase Inhibitor worldwide available liquid, ready to use, Alpha- ...

Ask a Question

Further Information

Related Condition Support Groups

Alpha-1 Proteinase Inhibitor Deficiency

Related Drug Support Groups

Prolastin, Zemaira, Prolastin-C, Aralast, Aralast NP, Glassia

Alpha 1-Proteinase Inhibitor Patient Information at Drugs.com